After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Boston Scientific Corp is $142.48B. A total of 15.69 million shares were traded on the day, compared to an average of 9.78M shares.
In the most recent transaction, Butcher Arthur C sold 17,313 shares of BSX for 101.55 per share on Dec 01 ’25. After the transaction, the EVP& Grp Pres, MedSurg & APAC now owns 23,600 company shares. In a previous transaction on Dec 01 ’25, ARTHUR C BUTCHER bought 17,313 shares at 101.55 per share.
Among the insiders who sold shares, Zane Ellen M disposed of 12,891 shares on Nov 06 ’25 at a per-share price of $98.28. This resulted in the Director holding 24,134 shares of BSX after the transaction. In another insider transaction, Fitzgerald Joseph Michael sold 50,000 shares at $99.47 per share on Nov 03 ’25. Company shares held by the EVP & Group Pres, Cardiology now total 178,342.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BSX has a high of $109.50 and a low of $85.98.
As of this writing, BSX has an earnings estimate of $0.78 per share for the current quarter. EPS was calculated based on a consensus of 27.0 estimates, with a high estimate of $0.81 per share and a lower estimate of $0.77. The company reported an EPS of $0.7 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $15.78, while its Total Shareholder’s Equity was $16.62B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.78.
